Behavior of serum human major histocompatibility complex class I antigen levels in human immunodeficiency virus-infected patients during antiretroviral therapy: Correlation with clinical outcome

Human Immunology

Volumn 68, Issue 11, 2007, Pages 894-900

  Murdaca, Giuseppe ^a   Contini, Paola ^a   Setti, Maurizio ^a   Cagnati, Paola ^a   Villa, Roberto ^a   Lantieri, Francesca ^b   Indiveri, Francesco ^a   Puppo, Francesco ^a  

^a UNIVERSITY OF GENOA   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

Author keywords

AIDS; HAART; HIV; Soluble HLA molecules

Indexed keywords

ANTIRETROVIRUS AGENT; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; SOLUBLE TUMOR NECROSIS FACTOR ALPHA RECEPTOR 2; TUMOR NECROSIS FACTOR ALPHA RECEPTOR; UNCLASSIFIED DRUG; VIRUS RNA;

ADULT; ARTICLE; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE MEMBRANE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; TREATMENT OUTCOME; VIROLOGY;

ADULT; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; BETA 2-MICROGLOBULIN; CD4 LYMPHOCYTE COUNT; FEMALE; HISTOCOMPATIBILITY ANTIGENS CLASS I; HIV; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE II; RNA, VIRAL; TREATMENT OUTCOME; VIRAL LOAD;

EID: 36849083561     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humimm.2007.09.008     Document Type: Article

References (32)

1. Puppo F., Brenci S., Lanza L., Bosco O., Imro M.A., Scudeletti M., et al. Increased level of serum HLA class I antigens in HIV infection. Correlation with disease progression. Hum Immunol 40 (1994) 259
2. Krangel M.S., Orr H.T., and Strominger J.L. Assembly and maturation of HLA-A and HLA-B antigens in vivo. Cell 18 (1979) 979
3. Ploegh H.L., Orr H.T., and Strominger J.L. Major histocompatibilty antigens: the human (HLA-A, -B, -C) and murine (H-2k, H-2D) class I molecules. Cell 24 (1981) 287
4. Allison J.P., Pellegrino M.A., Ferrone S., Callahan G.N., and Reisfeld R.A. Biologic and chemical characterization of HLA antigens in human serum. J Immunol 118 (1977) 1004
5. Pellegrino M.A., Russo C., and Allison J.P. HLA antigens in serum. Methods Enzymol 108 (1984) 614
6. Krangel M.S. Secretion of HLA-A and -B antigens via an alternative RNA splicing pathway. J Exp Med 163 (1986) 1173
7. Krangel M.S. Two forms of HLA class I molecules in human plasma. Hum Immunol 20 (1987) 155
8. Singh P.B., Brown R.E., and Roser B. Class I transplantation antigens in solution in body fluids and in the urine: individuality signals to the environment. J Exp Med 168 (1988) 195
9. Dobbe L.M.E., Stam N.J., Neefjes J.J., and Giphart M.J. Biochemical complexity of serum HLA class I molecules. Immunogenetics 27 (1988) 203
10. 2-microglobulin in acquired immunodeficiency syndrome (AIDS) patients. Clin Chem 29 (1983) 1560
11. 2-microglobulin and other immune characteristics in a perspective study of men at high risk for acquired immune deficiency syndrome. J Am Med Assoc 251 (1984) 2951
12. Fahey J.L., Taylor J.M.G., Detels R., Hofmann B., Melmed R., Nishanian P., et al. The prognostic value of cellular and serologic markers in infection with human immunodeficiency virus type 1. N Engl J Med 322 (1990) 166
13. Russo C., Fotino M., Carbonara A., and Ferrone S. A double determinant immunoassay for HLA class I typing using serum as an antigen source. Hum Immunol 19 (1987) 69
14. Barnstable C.J., Bodmer W.F., Brown G., Galfre G., Milstein C., Williams A.F., et al. Production of monoclonal antibodies to group A erythrocytes, HLA and other human cell surface antigens: new tools for genetic analysis. Cell 14 (1978) 9
15. Pellegrino M.A., Ng A.K., Russo C., and Ferrone S. Heterogeneous distribution of determinants defined by monoclonal antibodies on HLA-A and B antigens bearing molecules. Transplantation 34 (1982) 18
16. Tanabe M., Sekimata M., Ferrone S., and Takiguchi M. Structural and functional analysis of monomorphic determinants recognized by monoclonal antibodies reacting with the HLA class I α3 domain. J Immunol 148 (1992) 3202
17. Puppo F., Scudeletti M., Indiveri F., and Ferrone S. Serum HLA class I antigens: marker and modulators of an immune response?. Immunol Today 16 (1995) 124
18. 2-microglobulin and prediction of progression to AIDS in HIV infection. Lancet 339 (1992) 1436
19. 2-microglobulin level and CD4 lymphocyte count to predict development of acquired immunodeficiency syndrome in persons with human immunodeficiency infection. Arch Intern Med 150 (1990) 73
20. Maio M., Gulwani B., Langer J.A., Kerbel R.S., Duigou G.J., Fisher P.B., et al. Modulation by interferons of HLA antigen, high-molecular weight melanoma associated antigen, and intercellular adhesion molecule 1 expression by cultured meolanoma cells with different metastatic potential. Cancer Res 49 (1989) 2980
21. Aulitzky W.E., Grosse-Wilde H., Westhoff U., Tilg H., Aulitzky W., and Gastl G. Enhanced serum levels of soluble HLA class I molecules are induced by treatment with recombinant interferon-gamma (IFN-gamma). Clin Exp Immunol 86 (1991) 236
22. Hausmann R., Zavazava N., Steinmann J., and Muller-Ruchholts W. Interaction of papain-digested HLA class I molecules with human alloreactive cytotoxic T lymphocytes (CTL). Clin Exp Immunol 91 (1993) 183
23. Nixon D.F., and McMichael A.J. Cytotoxic T-cell recognition of HIV proteins and peptides. AIDS 5 (1991) 1049
24. Parham P., Clayberger C., Zorn S.L., Ludwig D.S., Schoolnik G.K., and Krensky A.M. Inhibition of alloreactive cytotoxic T lymphocytes by peptides from the alpha 2 domain of HLA-A2. Nature 325 (1987) 625
25. Spaggiari G.M., Contini P., Carosio R., Arvigo M., Ghio M., Oddone D., et al. Soluble HLA class I molecules induce natural killer cell apoptosis through the engagement of CD8. Evidence for a negative regulation exerted by CD94/NKG2A complex and KIR2D. Blood 99 (2002) 1706
26. Contini P., Ghio M., Poggi A., Filaci G., Indiveri F., Ferrone S., et al. Soluble HLA-A,-B,-C and -G molecules induce apoptosis in T and NK CD8+cells and inhibit cytotoxic T cell activity through CD8 ligation. Eur J Immunol 33 (2003) 125
27. Contini P., Ghio M., Merlo M., Poggi A., Indiveri F., and Puppo F. Apoptosis of antigen-apecific T lymphocytes upon the engagement of CD8 by soluble HLA Class I molecules is Fas Ligand/Fas mediated: evidence for the involvement of p56lck,calcium calmodulin kinase II, and calcium-independent protein kinase C signaling pathways and for NF-κB and NF-AT nuclear translocation. J Immunol 175 (2005) 7244
28. Puppo F., Brenci S., Montinaro E., Lanza L., Contini P., Scudeletti M., et al. Inhibition of alloreactive cytotoxic T cell activity by HIV-positive sera: potential role of circulating soluble HLA class I molecules. AIDS Res Hum Retrovir 10 (1994) 1061
29. Sulkowski M.S., Chaisson R.E., Karp C.L., Moore R.D., Margolick J.B., and Quinn T.C. The effect of acute infectious illnesses on plasma human immunodeficiency virus (HIV) type 1 load and the expression of serologic markers of immune activation among HIV-infected adults. J Infect Dis 178 (1998) 1642
30. Gougeon M.L. Apoptosis as an HIV strategy to escape immune attack. Nat Rev Immunol 3 (2003) 392
31. Badley A.D. In vitro and in vivo effects of HIV protease inhibitors on apoptosis. Cell Death Differ 12 (2005) 924
32. Grumet F.C., Krishnaswamy S., See-Tho K., Filvaroff E., and Hiraki D.D. Soluble form of an HLA-B7 class I antigen specifically suppresses human alloimmunization. Hum Immunol 40 (1994) 228